2009 to 2023 Saw Increase in Use of Technology, Glycemic Control in Type...
Prevalence of glycemic control and use of diabetes technology lowest in Hispanic, non-Hispanic Black, Medicaid-insured
ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes
Treatment linked to reduced rates of first occurrence of suicidal behaviors, substance misuse, transport accidents, criminality
26.5 Percent of Adults With Diabetes Used GLP-1 RA Injectables in 2024
Hispanic, Black non-Hispanic, White non-Hispanic adults more likely to use GLP-1 RA injectables than Asian non-Hispanics
Lebrikizumab Efficacious, Safe for Patients With Skin of Color, Eczema
64.4 percent of patients with postinflammatory hyperpigmented lesions at baseline experienced reduced hyperpigmentation at week 24
FDA Approves First Drug for Chronic Lung Condition Bronchiectasis
FDA Announces Resolution of IV Saline Solutions Shortage
Agency is continuing efforts with manufacturers to address other IV fluid shortages
Public Believes Dermatologic Side Effects From Cancer Treatment Are Common
Findings seen among both those previously treated for cancer and cancer-naive people
Ivabradine Aids Symptoms of Postural Orthostatic Tachycardia Syndrome
Patients with POTS treated with ivabradine have better heart-rate control when standing
Many Not Up to Date With Vaccines Would Accept Shots During ED Visits
46.4 percent said they would accept one or more missing vaccines if they could be provided during their ED visit
Few With Myelodysplastic Syndromes Receive Hypomethylating Agents
Odds of receiving HMAs lower for those 85 years and older, women, Black patients
